The Good, the Bad, and the Different: Deciphering Heterogeneity
Heterogeneity is the variation in, or diversity of, participants, interventions, and outcomes within or between studies and patients. Every day, pharmacy and medical managers in managed care organizations (MCOs) make critical treatment decisions based on their understanding of the nuances and impact of heterogeneity.
Heterogeneity is the variation in, or diversity of, participants, interventions, and outcomes within or between studies and patients. Every day, pharmacy and medical managers in managed care organizations (MCOs) make critical treatment decisions based on their understanding of the nuances and impact of heterogeneity.
Interested in learning more about this topic and earning 3.5 hours of CE/CME credit? We invite you to participate in a satellite symposium, "The Good, the Bad, and the Different: Deciphering Heterogeneity," being held in conjunction with the AMCP 2012 Educational Conference. The symposium, funded by a grant from the National Pharmaceutical Council, will be broadcast on October 3, 2012, 1 p.m.-5 p.m., from Cincinnati's Duke Energy Center.
This session will improve your knowledge, skills, and confidence about heterogeneity when evaluating evidence and developing policies regarding drug use. It will focus on processes for evaluating comparative effectiveness research (CER) evidence rather than on any one therapeutic area or medical intervention. Participants will gain a better working knowledge through discussion and interactive cases that demonstrate how heterogeneity of treatment effects influences treatment outcomes and vulnerability to adverse effects. By recognizing these factors, decision makers can make better use of the evidence and treatments to improve health in the population they serve.
Register online at http://cer.pharmacy.arizona.edu/regform. For more information, send an email to [email protected]. The lunch and symposium are free of charge.